SCHEMBL4842629

SCHEMBL4842629

CCCCCOc1ccc(C(=O)Nc2ccc(C(=O)/C=C3\NC(C)(C)Cc4ccc(OC)cc43)cc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
MAPT P10636 7/20 0.44
TSHR P16473 2/20 0.44
HSD17B10 Q99714 2/20 0.44
HPGD P15428 1/20 0.44
TAAR1 Q96RJ0 1/20 0.44
NR1H4 Q96RI1 2/20 0.44
SMN1; SMN2 Q16637 3/20 0.43
LMNA P02545 2/20 0.43
STAT3 P40763 1/20 0.43
KDM4E B2RXH2 4/20 0.43
NPC1 O15118 3/20 0.43
ALDH1A1 P00352 3/20 0.43
RAB9A P51151 2/20 0.43
CYP1A2 P05177 1/20 0.43
HIF1A Q16665 1/20 0.41
MCHR1 Q99705 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
STK25 O00506 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4842638 1.00 MEN1 (0.47) MEN1KMT2AMAPTTSHRHSD17B10
SCHEMBL4840643 0.99 MEN1 (0.47) MEN1KMT2AMAPTTSHRHSD17B10
SCHEMBL4840631 0.99 MEN1 (0.47) MEN1KMT2AMAPTTSHRHSD17B10
SCHEMBL4840613 0.98 MEN1 (0.48) MEN1KMT2AMAPTTSHRHSD17B10
SCHEMBL4840622 0.98 MEN1 (0.48) MEN1KMT2AMAPTTSHRHSD17B10
SCHEMBL4846605 0.92 NPC1 (0.53) MEN1KMT2AMAPTTSHRHSD17B10
SCHEMBL4846599 0.92 NPC1 (0.53) MEN1KMT2AMAPTTSHRHSD17B10
SCHEMBL4835246 0.91 NR1H4 (0.54) MEN1KMT2AMAPTNR1H4SMN1; SMN2
SCHEMBL4835259 0.91 NR1H4 (0.54) MEN1KMT2AMAPTNR1H4SMN1; SMN2
SCHEMBL4837503 0.91 PLK1 (0.47) MEN1KMT2AMAPTHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7378428-B2 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2008-05-27 US disclosed
US-20050222138-A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2005-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050222138-A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient PARK7, MMP8, CDK7 MEN1 1230/4885KMT2A 4642/4885MAPT 646/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.